Overexpression of NCL Inhibits Intratumoral Anti-Tumor Immunity and Glycolytic Activity in CD8+ T Cells by Unblocking MYC-Mediated Transcriptional Repression of TXNIP. This evidence concerns the gene CD8A and neoplasm.